Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States (13% of 2024 revenues), diagnostic products (20% of 2024 revenues), nutritional products (22% of 2024 revenues), and medical devices (45% of 2024 revenues).
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 2026-03-03 12:06:12 | 112.93 | -1.19 | -1.05 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABT | 0000001800 | ABBOTT LABORATORIES | US0028241000 | 549300JBDVIIMW4FW262 | 360698440 | NYSE | 2834 | Pharmaceutical Preparations | 1231 | IL | 100 ABBOTT PARK ROAD | ABBOTT PARK | IL | 60064-3500 | UNITED STATES | US | 2246676100 | 100 ABBOTT PARK ROAD, ABBOTT PARK, IL, 60064-3500 | 100 ABBOTT PARK ROAD, ABBOTT PARK, IL, 60064-3500 | — | Health care | 1888 | Robert B. Ford | 115,000 | http://abbott.com | 232,169,255,381 | 1,996,795,525 | 1,737,682,887 | Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States (13% of 2024 revenues), diagnostic products (20% of 2024 revenues), nutritional products (22% of 2024 revenues), and medical devices (45% of 2024 revenues). | 2026-02-26 15:08:21 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 232,169,255,381 | 55,095,271,422 | 31.1143 | 1,737,682,887 | 3,359,476 | 0.1937 |
| 2024 | 177,073,983,959 | -8,097,350,351 | -4.3729 | 1,734,323,411 | -860,878 | -0.0496 |
| 2023 | 185,171,334,310 | -933,711,880 | -0.5017 | 1,735,184,289 | -2,761,944 | -0.1589 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Hubert L. Allen | Secretary, Executive Vice President, General Counsel | 2024 | 911,154 | — | 2,095,365 | 1,094,700 | 540,170 | 7,981,335 |
| Lisa D. Earnhardt | Executive Vice President, Group President | 2024 | 879,269 | — | 2,016,528 | 1,249,200 | 130,047 | 6,558,461 |
| Robert B. Ford | Chief Executive Officer, Chairman Of The Board | 2024 | 1,500,000 | — | 8,226,593 | 2,861,250 | 618,998 | 22,777,075 |
| Philip P. Boudreau | Chief Financial Officer, Executive Vice President | 2024 | 884,039 | — | 2,693,071 | 1,224,700 | 74,748 | 8,225,746 |
| Daniel G. Salvadori | Executive Vice President, Group President | 2024 | 879,269 | — | 1,833,239 | 855,400 | 157,015 | 5,789,762 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 115,000 |
| 2024 | 114,000 |
| 2023 | 114,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 44,328,000,000 | 41,950,000,000 | 40,109,000,000 |
| Cost Of Revenue | 19,319,000,000 | 18,706,000,000 | 17,975,000,000 |
| Gross Profit | — | — | — |
| Research And Development Expenses | 2,942,000,000 | 2,844,000,000 | 2,741,000,000 |
| General And Administrative Expenses | 12,332,000,000 | 11,697,000,000 | 10,949,000,000 |
| Operating Expenses | 36,275,000,000 | 35,125,000,000 | 33,631,000,000 |
| Operating Income | 8,053,000,000 | 6,825,000,000 | 6,478,000,000 |
| Net Income | 6,524,000,000 | 13,402,000,000 | 5,723,000,000 |
| Earnings Per Share Basic | 3.73 | 7.67 | 3.28 |
| Earnings Per Share Diluted | 3.72 | 7.64 | 3.26 |
| Weighted Average Shares Outstanding Basic | 1,741,000,000 | 1,740,000,000 | 1,740,000,000 |
| Weighted Average Shares Outstanding Diluted | 1,748,000,000 | 1,748,000,000 | 1,749,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 8,522,000,000 | 7,616,000,000 | 6,896,000,000 |
| Marketable Securities Current | 417,000,000 | 351,000,000 | 383,000,000 |
| Accounts Receivable | 7,929,000,000 | 6,925,000,000 | 6,565,000,000 |
| Inventories | 6,488,000,000 | 6,194,000,000 | 6,570,000,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 25,996,000,000 | 23,656,000,000 | 22,670,000,000 |
| Marketable Securities Non Current | 918,000,000 | 886,000,000 | 799,000,000 |
| Property Plant And Equipment | 11,816,000,000 | 10,658,000,000 | 10,154,000,000 |
| Other Assets Non Current | 1,200,000,000 | 784,000,000 | 787,000,000 |
| Total Assets Non Current | 22,200,000,000 | 18,500,000,000 | 16,200,000,000 |
| Total Assets | 86,713,000,000 | 81,414,000,000 | 73,214,000,000 |
| Accounts Payable | 4,240,000,000 | 4,195,000,000 | 4,295,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 3,033,000,000 | 1,500,000,000 | 1,080,000,000 |
| Other Liabilities Current | 569,000,000 | 594,000,000 | 492,000,000 |
| Total Liabilities Current | 16,496,000,000 | 14,157,000,000 | 13,841,000,000 |
| Long Term Debt | 12,929,000,000 | 14,125,000,000 | 14,679,000,000 |
| Other Liabilities Non Current | 2,538,000,000 | 3,443,000,000 | 3,466,000,000 |
| Total Liabilities Non Current | — | — | — |
| Total Liabilities | — | — | — |
| Common Stock | 25,527,000,000 | 25,153,000,000 | 24,869,000,000 |
| Retained Earnings | 49,781,000,000 | 47,261,000,000 | 37,554,000,000 |
| Accumulated Other Comprehensive Income | -6,001,000,000 | -7,906,000,000 | -7,839,000,000 |
| Total Shareholders Equity | 52,130,000,000 | 47,664,000,000 | 38,603,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 1,434,000,000 | 1,340,000,000 | 1,277,000,000 |
| Share Based Compensation Expense | 664,000,000 | 673,000,000 | 644,000,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 652,000,000 | 691,000,000 | 356,000,000 |
| Change In Inventories | -195,000,000 | 58,000,000 | 232,000,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 954,000,000 | 356,000,000 | -760,000,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 9,566,000,000 | 8,558,000,000 | 7,261,000,000 |
| Purchases Of Marketable Securities | 167,000,000 | 169,000,000 | 159,000,000 |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 2,171,000,000 | 2,207,000,000 | 2,202,000,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | -18,000,000 | -9,000,000 | -22,000,000 |
| Cash From Investing Activities | -2,422,000,000 | -2,338,000,000 | -3,133,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 4,189,000,000 | 3,904,000,000 | 3,625,000,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 893,000,000 | 1,295,000,000 | 1,227,000,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | -82,000,000 | — | — |
| Cash From Financing Activities | -6,309,000,000 | -5,404,000,000 | -7,091,000,000 |
| Change In Cash | 906,000,000 | 720,000,000 | -2,986,000,000 |
| Cash At End Of Period | 8,522,000,000 | 7,616,000,000 | 6,896,000,000 |
| Income Taxes Paid | 1,933,000,000 | 1,723,000,000 | 1,475,000,000 |
| Interest Paid | 545,000,000 | 604,000,000 | 662,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 3.73 | 7.67 | 3.28 |
| Price To Earnings Ratio | 33.5898 | 14.7471 | 33.5579 |
| Earnings Growth Rate | -51.369 | 133.8415 | -16.7513 |
| Price Earnings To Growth Ratio | -0.6539 | 0.1102 | -2.0033 |
| Book Value Per Share | 40.3314 | 38.6534 | 34.1224 |
| Price To Book Ratio | 3.1065 | 2.9263 | 3.2257 |
| Ebitda | 10,384,000,000 | 17,024,000,000 | 9,112,000,000 |
| Enterprise Value | 225,569,890,000 | 204,820,400,000 | 200,384,800,000 |
| Dividend Yield | 0.0192 | 0.0198 | 0.0189 |
| Dividend Payout Ratio | 0.6421 | 0.2913 | 0.6334 |
| Debt To Equity Ratio | 0.3062 | 0.3278 | 0.4082 |
| Capital Expenditures | 2,592,000,000 | 1,844,000,000 | 2,269,000,000 |
| Free Cash Flow | 6,974,000,000 | 6,714,000,000 | 4,992,000,000 |
| Return On Equity | 0.1251 | 0.2812 | 0.1483 |
| One Year Beta | 0.2285 | 0.1988 | 0.5808 |
| Three Year Beta | 0.3066 | 0.6741 | 0.727 |
| Five Year Beta | 0.5417 | 0.762 | 0.8225 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Ford Robert B | Director, CHAIRMAN AND CEO | 2026-02-24 | 83,464 | A | 336,769 |
| Ford Robert B | Director, CHAIRMAN AND CEO | 2026-02-24 | 344,066 | A | 344,066 |
| Boudreau Philip P | EVP AND CFO | 2026-02-24 | 27,997 | A | 78,613 |
| Boudreau Philip P | EVP AND CFO | 2026-02-24 | 115,413 | A | 115,413 |
| Cushman Elizabeth C. | EVP, GC AND SECRETARY | 2026-02-24 | 15,031 | A | 40,257 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Shelley M Capito | Senator | 2025-03-06 | Sale (Partial) | 2025-02-24 | Spouse | $1,001 - $15,000 |
| Markwayne Mullin | Senator | 2025-01-31 | Sale (Full) | 2025-01-08 | Joint | $1,001 - $15,000 |
| Markwayne Mullin | Senator | 2024-12-31 | Sale (Partial) | 2024-12-11 | Joint | $15,001 - $50,000 |
| Thomas R Carper | Senator | 2024-02-02 | Sale (Partial) | 2024-01-17 | Spouse | $1,001 - $15,000 |
| Markwayne Mullin | Senator | 2023-11-01 | Purchase | 2023-10-03 | Joint | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Thomas H. Kean | 2026-02-19 | NJ07 | Purchase | 2026-01-29 | — | $1,001 - $15,000 |
| Julie Johnson | 2026-01-15 | TX32 | Sale | 2025-12-18 | Joint | $1,001 - $15,000 |
| Julia Letlow | 2026-01-13 | LA05 | Sale | 2025-12-08 | — | $1,001 - $15,000 |
| Julia Letlow | 2026-01-13 | LA05 | Purchase | 2024-10-23 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2026-01-12 | CA31 | Sale (Partial) | 2025-12-19 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| NWF Advisory Services Inc. | 2025-12-31 | 1,409,417 | 11,249 | 125.2926 |
| TOBAM | 2025-12-31 | 749,000 | 5,981 | 125.2299 |
| NCM Capital Management, LLC | 2025-12-31 | 549,605 | 4,387 | 125.2804 |
| Strategic Investment Solutions, Inc. /IL | 2025-12-31 | 62,922 | 503 | 125.0934 |
| GROUPAMA ASSET MANAGMENT | 2025-12-31 | 8,033,845 | 64,122 | 125.29 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| AZZAD FUNDS | 2025-12-31 | Azzad Wise Capital Fund | WISEX | 4,410 | 552,528.9 | 0.15 |
| JAMES ADVANTAGE FUNDS | 2025-12-31 | Institutional Class | GLRIX | 19,650 | 2,461,948.5 | 0.5911 |
| JAMES ADVANTAGE FUNDS | 2025-12-31 | Retail Class | GLRBX | 19,650 | 2,461,948.5 | 0.5911 |
| PIMCO Equity Series | 2025-12-31 | PIMCO RAFI ESG U.S. ETF | RAFE | 10,163 | 1,273,322.27 | 1.0646 |
| PIMCO Equity Series | 2025-12-31 | PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF | MFUS | 2,699 | 338,157.71 | 0.1607 |